Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -8 of 8
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
Last Modified:
1/13/2009
 
First Published:
5/11/2006
1.
Phase III Randomized Study of Zoledronate in Preventing Osteoporosis and Associated Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiotherapy and Luteinizing Hormone-Releasing Hormone Agonist Therapy
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Active
18 and over
NCI
RTOG-0518
0518, NCT00329797
Last Modified:
1/14/2009
 
First Published:
8/13/2006
2.
Phase III Randomized Study of Zoledronate, Vitamin D, and Calcium With or Without Strontium Chloride Sr 89 or Samarium Sm 153 Lexidronam Pentasodium in Preventing or Delaying Skeletal-Related Events in Patients With Bone Metastases Secondary to Prostate, Lung, or Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care
Active
18 and over
NCI
RTOG-0517
RTOG 0517, NCT00365105
3.
A Study of Actonel for the Prevention of Bone Loss
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Supportive care, Treatment
Active
18 and over
Other
ID03-0124
NCT00452439
4.
Chemoprevention of Colorectal Adenomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Prevention
Active
40 to 75
Pharmaceutical / Industry
COLO CP-01-US
NCT00486512
Last Modified:
9/3/2008
 
First Published:
4/21/2006
5.
Phase II Randomized Study of Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Supportive care, Treatment
Active
18 and over
NCI, Pharmaceutical / Industry
UMN-2005NT018
UMN-0506M70866, UMN-MT2005-06, NOVARTIS-CZOL446EUS29, NCT00321932
Last Modified:
10/30/2008
 
First Published:
12/21/2006
6.
Phase II Pilot Study of Vitamin D Deficiency and Myalgias and/or Arthralgias in Postmenopausal Women Receiving Adjuvant Letrozole for Stage I-III Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase II
Natural history/Epidemiology, Supportive care, Treatment
Active
18 and over
NCI, Pharmaceutical / Industry
UWCC-6346
6346, NOVARTIS-UWCC-6346, UWCC-06-2386-H/A, FHCRC-6346, NCT00416715
7.
Effect of Vitamin D and Calcium on Genes in the Colon
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase I
Biomarker/Laboratory analysis, Prevention
Active
48 to 72
Other
RUH IRB # PHO-0554
NCT00298545
8.
Study of Adults With Low Growth Hormone Who Survived Childhood Cancer Where Treatment Caused Low Bone Density
Phase
Type
Status
Age
Sponsor
Protocol IDs
No phase specified
Supportive care
Active
18 and over
Other
SUNY UMU IRB # 4689
NCT00145704
Select All on One Page
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute